Randomized phase 3 trial of irinotecan (CPT-11) + 5FU/folinic acid (FA) vs CDDP + 5FU in 1<sup>st</sup>-line advanced gastric cancer patients

200587 citationsJournal Article

Authors

4003

Good health and well-being

Published in: Journal of Clinical Oncology

Volume 23, Issue 16_suppl, pp. 4003-4003

Field-Weighted Citation Impact: 15.56